Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
893 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06081452 | Public Survey on Breath Testing for Health and Disease | recruiting | — | 1,000 | Imperial College LondonOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06627036 | Dermoscopy vs Standard Marking for the Completeness of Excision of Keratinocyte Skin Cancers: The ClearMark Trial(ClearMark) | recruiting | Phase 4 | 1,376 | Hull University Teaching Hospitals NHS TrustOTHER_GOV | 1 | Jan 24, 2025 |
| clinicaltrials |
| NCT06554587 | Investigation of Three Biomarkers for the Detection of Prostate Cancer | recruiting | — | 137 | Medtechtomarket Consulting LtdINDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
| NCT05364788 | Molecular Characterisation of Appendiceal Cancer | recruiting | — | 100 | The Christie NHS Foundation TrustOTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT05513716 | Molecular Characterisation of Colorectal Cancer Peritoneal Metastases(COLOMET II) | recruiting | — | 200 | The Christie NHS Foundation TrustOTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT06071871 | A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma(PORTAL) | recruiting | Phase 2 | 99 | University College, LondonOTHER | 1 | Dec 24, 2024 | clinicaltrials |
| NCT06640959 | Chronic Radiation Induced Bowel Toxicity Study(CRIBS) | recruiting | — | 50 | The Christie NHS Foundation TrustOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT05055648 | PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy(PROTECT) | recruiting | Phase 3 | 396 | University of AarhusOTHER | 8 | Dec 17, 2024 | clinicaltrials |
| NCT05989854 | The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer | recruiting | N/A | 50 | University of SurreyOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT05064124 | Early DiAgnosis Real-Time Healthcare System for CANcer Trial(EARTHSCAN) | recruiting | — | 420 | University College, LondonOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT06575439 | An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK(OLIVE) | recruiting | — | 225 | University College London HospitalsOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06728527 | PARTial BREast RECONstruction With Chest Wall Perforator Flap(PartBreCon) | recruiting | — | 1,001 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06423690 | First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System | recruiting | N/A | 15 | Snipe MedicalINDUSTRY | 3 | Dec 10, 2024 | clinicaltrials |
| NCT05185739 | Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)(PRIMER-1) | recruiting | Phase 2 | 60 | University College, LondonOTHER | 1 | Dec 6, 2024 | clinicaltrials |
| NCT03911297 | DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome(DAISy-PCOS) | recruiting | — | 1,000 | Imperial College LondonOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT04985266 | A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer(TRAK-ER) | recruiting | Phase 2 | 1,100 | Royal Marsden NHS Foundation TrustOTHER | 2 | Dec 5, 2024 | clinicaltrials |
| NCT06016075 | Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques(IBM-Renal) | recruiting | N/A | 30 | University of CambridgeOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06712095 | Video Capsule Examination in Patients With Lynch Syndrome(PILLCAM) | recruiting | N/A | 25 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT02549157 | Treatments for Urogynaecological Problems and Patient Selfreports | recruiting | — | 500 | Swansea UniversityOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT03860883 | Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma(MelMarT-II) | recruiting | N/A | 2,998 | Melanoma and Skin Cancer Trials LimitedOTHER | 10 | Nov 27, 2024 | clinicaltrials |
| NCT05718726 | Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI)(OPSI) | recruiting | — | 300 | Hampshire Hospitals NHS Foundation TrustOTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT05967143 | Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)(SIRtain) | recruiting | — | 845 | Sirtex MedicalINDUSTRY | 3 | Nov 27, 2024 | clinicaltrials |
| NCT06695234 | Effects of a Second-generation Mindfulness-based Intervention on Quality of Life, Pain Management, and Psycho-spiritual Wellbeing in Cancer Patients: A Randomised Controlled Trial | recruiting | N/A | 200 | University of DerbyOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT05965479 | Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer(DECIPHER) | recruiting | Phase 2 | 25 | University of SouthamptonOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06682936 | Feasibility of Ambulatory Talc. Pleurodesis | recruiting | N/A | 15 | David RollinsOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT05254171 | Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer(ASPIRE) | recruiting | Phase 2 / Phase 3 | 600 | Panbela Therapeutics, Inc.INDUSTRY | 10 | Nov 6, 2024 | clinicaltrials |
| NCT06579417 | ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer(ART-Pro) | recruiting | — | 500 | University of California, San DiegoOTHER | 2 | Nov 6, 2024 | clinicaltrials |
| NCT06123676 | Introduction of Y90-PET-CT Post Radioembolisation Therapy Scans(Y90-PET-CT) | recruiting | N/A | 10 | The Christie NHS Foundation TrustOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT04103372 | Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery(PRESERVE) | recruiting | N/A | 200 | Imperial College LondonOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06646341 | EMVI as a Determinant of Metastasis in Colorectal Cancer(EVIDENCE) | recruiting | — | 100 | Imperial College LondonOTHER | 1 | Nov 1, 2024 | clinicaltrials |
| NCT02222844 | Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers(IMPRESS) | recruiting | N/A | 244 | Imperial College LondonOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT02246634 | Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)(SERENADE) | recruiting | N/A | 282 | Imperial College LondonOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT02292641 | Beyond TME Origins | recruiting | N/A | 383 | Imperial College LondonOTHER | 2 | Oct 17, 2024 | clinicaltrials |
| NCT02579278 | Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous Invasion(ctDNA) | recruiting | — | 100 | Imperial College LondonOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT02704520 | Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial(TRIGGER) | recruiting | N/A | 441 | Imperial College LondonOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT03303547 | Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits(COMET) | recruiting | N/A | 200 | Imperial College LondonOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT05902559 | Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks(ALPINE) | recruiting | — | 10,000 | University College, LondonOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06638593 | MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm.(MIRRORS-FROZEN) | recruiting | N/A | 40 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT04498221 | Lymphatic Mapping Of Oropharyngeal Cancer(LOOC) | recruiting | N/A | 150 | University College, LondonOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05613023 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT(PACE-NODES) | recruiting | Phase 3 | 1,128 | Institute of Cancer Research, United KingdomOTHER | 3 | Sep 19, 2024 | clinicaltrials |
| NCT06572475 | USPIO Enhanced MR Imaging in CNS Tumours (UMIC)(UMIC) | recruiting | N/A | 17 | Northern Care Alliance NHS Foundation TrustOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT03827317 | HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer | recruiting | N/A | 24 | Imperial College LondonOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE) | recruiting | N/A | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 26, 2024 | clinicaltrials |
| NCT05734963 | ORganoid GeneratioN Study for Cancer(ORIGINS) | recruiting | — | 100 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05837260 | Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer(NOMINATE) | recruiting | — | 120 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05933889 | Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer(SCORE) | recruiting | — | 250 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT04132895 | ICONIC: Improving Outcomes Through Collaboration in OsteosarComa(ICONIC) | recruiting | — | 300 | University College, LondonOTHER | 1 | Aug 2, 2024 | clinicaltrials |
| NCT03222635 | Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma(PREFER) | recruiting | N/A | 225 | Amsterdam UMCOTHER | 6 | Jul 24, 2024 | clinicaltrials |
| NCT06112964 | Neurobehavioural and Cognitive Changes in Cancer Cachexia (CANCOG)(CANCOG) | recruiting | — | 50 | University of CambridgeOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT06501846 | Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.(PUG) | recruiting | N/A | 92 | Imperial College Healthcare NHS TrustOTHER | 1 | Jul 15, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials